Search research articles
Contact Us
Filters
Showing results (31-40 of 45) with videos related to
Page
of 5
Sort By:
ESMO Real World Data and Digital Oncology
|
February 6, 2026
Treatment toxicities and pathological response through the evolution of neoadjuvant regimens in early triple-negative breast cancer
E Arnaud, P Vaflard, L Escalup, et al.
Cancer Medicine
|
July 6, 2023
Compliance to genomic test recommendations to guide adjuvant chemotherapy decision-making in the case of hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer, in real-life settings
D Hequet, N Hajjaji, E Charafe-Jauffret, et al.
Genes, Chromosomes & Cancer
|
May 25, 1999
Deletion mapping of the tumor suppressor locus involved in colorectal cancer on chromosome band 8p21
F Lerebours, S Olschwang, B Thuille, et al.
ESMO Open
|
November 29, 2024
Characteristics, treatment patterns and survival of patients with high-risk early hormone receptor-positive breast cancer in French real-world settings: an exploratory study of the CANTO cohort
F Giugliano, A Bertaut, J Blanc, et al.
Gastroenterologie Clinique Et Biologique
|
January 1, 1997
[Localization of a tumor suppressor gene distal to D22S270 in colorectal cancers]
C Duriez, A Schmitz, P Fouchet, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 7, 2018
5-year overall survival after early breast cancer diagnosed during pregnancy: A retrospective case-control multicentre French study
A Ploquin, B Pistilli, E Tresch, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 7, 2015
UNICANCER-PEGASE 07 study: a randomized phase III trial evaluating postoperative docetaxel-5FU regimen after neoadjuvant dose-intense chemotherapy for treatment of inflammatory breast cancer
A Gonçalves, J-Y Pierga, J-M Ferrero, et al.
Oncogene
|
July 26, 2011
A refined molecular taxonomy of breast cancer
M Guedj, L Marisa, A de Reynies, et al.
ESMO Open
|
July 25, 2021
Metastatic inflammatory breast cancer: survival outcomes and prognostic factors in the national, multicentric, and real-life French cohort (ESME)
D Dano, A Lardy-Cleaud, A Monneur, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 12, 2018
Letrozole and palbociclib versus chemotherapy as neoadjuvant therapy of high-risk luminal breast cancer
P Cottu, V D'Hondt, S Dureau, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 45) with videos related to
Sort By:
Page
of 5
ESMO Real World Data and Digital Oncology
|
February 6, 2026
Treatment toxicities and pathological response through the evolution of neoadjuvant regimens in early triple-negative breast cancer
E Arnaud, P Vaflard, L Escalup, et al.
Cancer Medicine
|
July 6, 2023
Compliance to genomic test recommendations to guide adjuvant chemotherapy decision-making in the case of hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer, in real-life settings
D Hequet, N Hajjaji, E Charafe-Jauffret, et al.
Genes, Chromosomes & Cancer
|
May 25, 1999
Deletion mapping of the tumor suppressor locus involved in colorectal cancer on chromosome band 8p21
F Lerebours, S Olschwang, B Thuille, et al.
ESMO Open
|
November 29, 2024
Characteristics, treatment patterns and survival of patients with high-risk early hormone receptor-positive breast cancer in French real-world settings: an exploratory study of the CANTO cohort
F Giugliano, A Bertaut, J Blanc, et al.
Gastroenterologie Clinique Et Biologique
|
January 1, 1997
[Localization of a tumor suppressor gene distal to D22S270 in colorectal cancers]
C Duriez, A Schmitz, P Fouchet, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 7, 2018
5-year overall survival after early breast cancer diagnosed during pregnancy: A retrospective case-control multicentre French study
A Ploquin, B Pistilli, E Tresch, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 7, 2015
UNICANCER-PEGASE 07 study: a randomized phase III trial evaluating postoperative docetaxel-5FU regimen after neoadjuvant dose-intense chemotherapy for treatment of inflammatory breast cancer
A Gonçalves, J-Y Pierga, J-M Ferrero, et al.
Oncogene
|
July 26, 2011
A refined molecular taxonomy of breast cancer
M Guedj, L Marisa, A de Reynies, et al.
ESMO Open
|
July 25, 2021
Metastatic inflammatory breast cancer: survival outcomes and prognostic factors in the national, multicentric, and real-life French cohort (ESME)
D Dano, A Lardy-Cleaud, A Monneur, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 12, 2018
Letrozole and palbociclib versus chemotherapy as neoadjuvant therapy of high-risk luminal breast cancer
P Cottu, V D'Hondt, S Dureau, et al.
Page
of 5